Redshift Bio

The Future of Biomolecule Structural Analysis

BOXBOROUGH, United States · $26.4M raised

Employees
51–200
Business Model
B2B
Total Funding
$26.4M
Last Round
$20.0M Series EOct 2021
Rounds
2

About

RedShiftBio (RedShift BioAnalytics, Inc.) is a life sciences instrumentation company that has developed a proprietary platform combining Microfluidic Modulation Spectroscopy (MMS) and high-powered quantum cascade lasers to provide ultra-sensitive, ultra-precise measurements of biomolecular structure and concentration. Their Aurora and Aurora TX instruments and HaLCon bioprocess analytics platform are used by leading biopharmaceutical companies and CDMOs worldwide to characterize proteins, RNA, and other biomolecules during drug development and manufacturing. RedShiftBio is backed by Waters Corporation, Illumina Ventures, and Technology Venture Partners, and is headquartered in Boxborough, Massachusetts.

Summary

Redshift Bio is a Biotech company based in BOXBOROUGH, United States. It has raised $26.4M in total across 2 rounds, most recently a $20.0M Series E round in Oct 2021. Investors include Illumina Ventures, Technology Venture Partners and Waters Corporation.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries EOct 2021
$20.0M

Sign up to see all 2 rounds

Extension Round through Series E — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Redshift Bio on Indexed.vc
<a href="https://indexed.vc/companies/redshift-bio"><img src="https://indexed.vc/api/badge/company/redshift-bio" alt="Redshift Bio on Indexed.vc" width="260" height="76" /></a>